Benjamin Jen

Director/Board Member at JIANGSU CNANO TECHNOLOGY CO., LTD.

58 year

Electronic Technology

Finance

Producer Manufacturing

Profile

Benjamin C.
M.
Jen is the founder of GRC Sinogreen Investment Advisor (Beijing) Co. Ltd.
founded in 2005, where he holds the title of Managing Partner.
Currently, he holds the position of Director at Jiangsu Cnano Technology Co., Ltd.
since 2015, Director at Applied BioCode Corp.
since 2016, and Director at Applied BioCode, Inc. He previously held the position of Director at Applied Optoelectronics, Inc. Mr. Jen's education history includes an undergraduate degree from the University of Missouri and an MBA from the Massachusetts Institute of Technology.

Benjamin Jen active positions

Companies	Position	Start
JIANGSU CNANO TECHNOLOGY CO., LTD.	Director/Board Member	01/03/2015
APPLIED BIOCODE CORPORATION	Director/Board Member	29/09/2016
GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. Investment ManagersFinance GRC SinoGreen Investment Advisor (Beijing) Co. Ltd. (GRC SinoGreen Fund) is an independent private equity/venture capital firm founded in 2005 by Yuan-Chi Chao and Benjamin Jen. GRC SinoGreen Fund is headquartered in Beijing and has offices in Taipei and Shenzhen.	Founder	01/01/2005
Applied BioCode, Inc. Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The private company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022.	Director/Board Member	-

All active positions of Benjamin Jen

Former positions of Benjamin Jen

Companies	Position	End
APPLIED OPTOELECTRONICS, INC.	Director/Board Member	27/02/2013

See the detail of Benjamin Jen's experience

Training of Benjamin Jen

University of Missouri	Undergraduate Degree
Massachusetts Institute of Technology	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Benjamin Jen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
APPLIED OPTOELECTRONICS, INC.	Electronic Technology
JIANGSU CNANO TECHNOLOGY CO., LTD.	Producer Manufacturing
APPLIED BIOCODE CORPORATION	Health Technology

Private companies	2
GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. GRC Sinogreen Investment Advisor (Beijing) Co. Ltd. Investment ManagersFinance GRC SinoGreen Investment Advisor (Beijing) Co. Ltd. (GRC SinoGreen Fund) is an independent private equity/venture capital firm founded in 2005 by Yuan-Chi Chao and Benjamin Jen. GRC SinoGreen Fund is headquartered in Beijing and has offices in Taipei and Shenzhen.	Finance
Applied BioCode, Inc. Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The private company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022.	Electronic Technology